244 related articles for article (PubMed ID: 1526645)
1. Francisella tularensis--a model for studies of the immune response to intracellular bacteria in man.
Tärnvik A; Eriksson M; Sandström G; Sjöstedt A
Immunology; 1992 Jul; 76(3):349-54. PubMed ID: 1526645
[No Abstract] [Full Text] [Related]
2. Nature of protective immunity to Francisella tularensis.
Tärnvik A
Rev Infect Dis; 1989; 11(3):440-51. PubMed ID: 2665002
[TBL] [Abstract][Full Text] [Related]
3. Diversity of Francisella tularensis Schu4 antigens recognized by T lymphocytes after natural infections in humans: identification of candidate epitopes for inclusion in a rationally designed tularemia vaccine.
McMurry JA; Gregory SH; Moise L; Rivera D; Buus S; De Groot AS
Vaccine; 2007 Apr; 25(16):3179-91. PubMed ID: 17291638
[TBL] [Abstract][Full Text] [Related]
4. Dominance of human innate immune responses in primary Francisella tularensis live vaccine strain vaccination.
Fuller CL; Brittingham KC; Hepburn MJ; Martin JW; Petitt PL; Pittman PR; Bavari S
J Allergy Clin Immunol; 2006 May; 117(5):1186-8. PubMed ID: 16675351
[No Abstract] [Full Text] [Related]
5. Tularemia vaccines - an overview.
McMurry JA; Moise L; Gregory SH; De Groot AS
Med Health R I; 2007 Oct; 90(10):311-4. PubMed ID: 18019188
[TBL] [Abstract][Full Text] [Related]
6. [Tularemia vaccine strain is a potential vector].
Pavlov VM; Mokrievich AN; Noskov AN; Urakov NN
Vestn Ross Akad Med Nauk; 1997; (6):30-2. PubMed ID: 9289276
[TBL] [Abstract][Full Text] [Related]
7. Vaccines against Francisella tularensis.
Wayne Conlan J; Oyston PC
Ann N Y Acad Sci; 2007 Jun; 1105():325-50. PubMed ID: 17395730
[TBL] [Abstract][Full Text] [Related]
8. Vaccination strategies for Francisella tularensis.
Isherwood KE; Titball RW; Davies DH; Felgner PL; Morrow WJ
Adv Drug Deliv Rev; 2005 Jun; 57(9):1403-14. PubMed ID: 15919131
[TBL] [Abstract][Full Text] [Related]
9. Generation of heterogeneous memory T cells by live attenuated tularemia vaccine in humans.
Salerno-Gonçalves R; Hepburn MJ; Bavari S; Sztein MB
Vaccine; 2009 Dec; 28(1):195-206. PubMed ID: 19799845
[TBL] [Abstract][Full Text] [Related]
10. Progress, challenges, and opportunities in Francisella vaccine development.
Elkins KL; Kurtz SL; De Pascalis R
Expert Rev Vaccines; 2016 Sep; 15(9):1183-96. PubMed ID: 27010448
[TBL] [Abstract][Full Text] [Related]
11. Adaptive Immunity to
Roberts LM; Powell DA; Frelinger JA
Front Cell Infect Microbiol; 2018; 8():115. PubMed ID: 29682484
[No Abstract] [Full Text] [Related]
12. Loss of either CD4+ or CD8+ T cells does not affect the magnitude of protective immunity to an intracellular pathogen, Francisella tularensis strain LVS.
Yee D; Rhinehart-Jones TR; Elkins KL
J Immunol; 1996 Dec; 157(11):5042-8. PubMed ID: 8943413
[TBL] [Abstract][Full Text] [Related]
13. Humoral and cell-mediated immunity to the intracellular pathogen Francisella tularensis.
Kirimanjeswara GS; Olmos S; Bakshi CS; Metzger DW
Immunol Rev; 2008 Oct; 225():244-55. PubMed ID: 18837786
[TBL] [Abstract][Full Text] [Related]
14. [ROLE OF VARIOUS ANTIGENIC PREPARATIONS OF FRANCISELLA TULARENSIS IN FORMATION OF ALLERGY REACTION IN HUMANS AND ANIMALS].
Onoprienko NN; Aronova NV; Pavlovich NV
Zh Mikrobiol Epidemiol Immunobiol; 2016; (1):22-9. PubMed ID: 27029112
[TBL] [Abstract][Full Text] [Related]
15. Expansion of Vgamma9 Vdelta2 T cells is triggered by Francisella tularensis-derived phosphoantigens in tularemia but not after tularemia vaccination.
Poquet Y; Kroca M; Halary F; Stenmark S; Peyrat MA; Bonneville M; Fournié JJ; Sjöstedt A
Infect Immun; 1998 May; 66(5):2107-14. PubMed ID: 9573096
[TBL] [Abstract][Full Text] [Related]
16. A Francisella tularensis subspecies novicida purF mutant, but not a purA mutant, induces protective immunity to tularemia in mice.
Quarry JE; Isherwood KE; Michell SL; Diaper H; Titball RW; Oyston PC
Vaccine; 2007 Mar; 25(11):2011-8. PubMed ID: 17241711
[TBL] [Abstract][Full Text] [Related]
17. Virulence determinants and protective antigens of Francisella tularensis.
Sjöstedt A
Curr Opin Microbiol; 2003 Feb; 6(1):66-71. PubMed ID: 12615222
[TBL] [Abstract][Full Text] [Related]
18. [The determination of the duration of postvaccinal immunity against tularemia].
Savel'eva RA; Ananova EV; Pronin AV; Fominykh EA; Rodionova IV
Zh Mikrobiol Epidemiol Immunobiol; 1995; (6):51-2. PubMed ID: 8553755
[No Abstract] [Full Text] [Related]
19. CD4-CD8- T cells control intracellular bacterial infections both in vitro and in vivo.
Cowley SC; Hamilton E; Frelinger JA; Su J; Forman J; Elkins KL
J Exp Med; 2005 Jul; 202(2):309-19. PubMed ID: 16027239
[TBL] [Abstract][Full Text] [Related]
20. Francisella tularensis vaccines.
Oyston PC
Vaccine; 2009 Nov; 27 Suppl 4():D48-51. PubMed ID: 19837286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
